Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic ciprofloxacin during viral respiratory infections in children with cystic fibrosis to prevent Pseudomonas aeruginosa colonisation
2008-001769-27Phase 4Unknown
- Sponsor
- University Hospital Southampton
- Start
- Oct 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cystic fibrosis (CF) and Pseudomonal infection comparing Ciproxin prophylaxis with Placebo (2 arms). Primary endpoint: Pseudomonas aeruginosa positive isolates. Status: unknown.
02
Drugs
ciprofloxacin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2008-001769-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001769-27.